Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Bullboard Posts
Post by sandymackayon Oct 04, 2011 8:20pm
255 Views
Post# 19119219

Green in a Sea of Red

Green in a Sea of RedSomething brewing? Spoke with few CFR staff recently, not IR since they never returned my call,and was pleased to hear that their marketing efforts are progressing well. I asked whether  teaming up with a major Pharma to help market Oximunol was something they were considering, and I believe that to be the case ( IMHO).  Tacey Gillete is a vet with the company and was very helpful in explaining the possible uses of Oximunol in the future and their Stem-cell therapy. I think I recall her saying that Oximunol is less than a year old so it will take some time to get the name out there. I did my part by refering CFR-Oximunol to a few VETs in the Niagara Region. Every little bit of marketing helps and Im happy to do my part. I think there will be some developments as CFR looks to expand Oximunol to treat cats and eventually break into the agri-feed industry.

Sandy
Bullboard Posts